The Effectiveness and Safety of Dong-A Opalmon® Tablet in Patients With Acquired Lumbar Spinal Stenosis

Dong-A ST

Status: Enrolling

Conditions: Lumbar Spinal Stenosis

Study type: Observational

Funder types: Industry

Identifiers

NCT06654856

OMT_LSS_OS

Details and patient eligibility

About

This study is to evaluate the Effectiveness and Safety of Dong-A Opalmon® Tablet in Patients With Acquired Lumbar Spinal Stenosis

Enrollment: 116 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Men or women aged ≥ 19 years
• Subjects with acquired Lumbar Spinal Stenosis who show normal results in the Straight Leg Raising (SLR) test and exhibit intermittent claudication, requiring treatment with Dong-A Opalmon® tab
• Subjects who voluntarily consent to participate in this observational study

Exclusion criteria

• Subject for whom the medicinal products administration is contraindicated according to the approved domestic drug information: Pregnant women or those who may be pregnant, Subject with genetic disorders such as galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption
• Subjects considered as unsuitable for participation in this observational study by the principal investigator or sub-investigator

Trial design

116 participants in 1 patient group

Dong-A Opalmon® Tab